NL2037597A - Method for screening lactobacillus casei fermentation agent metabolizing sucrose - Google Patents
Method for screening lactobacillus casei fermentation agent metabolizing sucrose Download PDFInfo
- Publication number
- NL2037597A NL2037597A NL2037597A NL2037597A NL2037597A NL 2037597 A NL2037597 A NL 2037597A NL 2037597 A NL2037597 A NL 2037597A NL 2037597 A NL2037597 A NL 2037597A NL 2037597 A NL2037597 A NL 2037597A
- Authority
- NL
- Netherlands
- Prior art keywords
- sucrose
- tested
- lactobacillus casei
- add
- casei
- Prior art date
Links
- 244000199866 Lactobacillus casei Species 0.000 title claims abstract description 73
- 235000013958 Lactobacillus casei Nutrition 0.000 title claims abstract description 73
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 title claims abstract description 73
- 229930006000 Sucrose Natural products 0.000 title claims abstract description 73
- 229940017800 lactobacillus casei Drugs 0.000 title claims abstract description 73
- 239000005720 sucrose Substances 0.000 title claims abstract description 73
- 238000000855 fermentation Methods 0.000 title claims abstract description 36
- 230000004151 fermentation Effects 0.000 title claims abstract description 36
- 238000000034 method Methods 0.000 title claims abstract description 27
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 19
- 238000012216 screening Methods 0.000 title claims abstract description 16
- 235000015140 cultured milk Nutrition 0.000 claims abstract description 23
- 239000000243 solution Substances 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 17
- 238000005119 centrifugation Methods 0.000 claims description 16
- 101150082821 sacA gene Proteins 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 241000894006 Bacteria Species 0.000 claims description 11
- 108020004414 DNA Proteins 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 10
- 239000001963 growth medium Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 8
- 239000008367 deionised water Substances 0.000 claims description 7
- 229910021641 deionized water Inorganic materials 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 230000003321 amplification Effects 0.000 claims description 6
- 229940088598 enzyme Drugs 0.000 claims description 6
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 6
- 239000002699 waste material Substances 0.000 claims description 6
- 241000186660 Lactobacillus Species 0.000 claims description 5
- 230000003213 activating effect Effects 0.000 claims description 5
- 239000007853 buffer solution Substances 0.000 claims description 5
- 238000012258 culturing Methods 0.000 claims description 5
- 238000001514 detection method Methods 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 claims description 5
- 229940039696 lactobacillus Drugs 0.000 claims description 5
- 238000009630 liquid culture Methods 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 230000004060 metabolic process Effects 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 108010067770 Endopeptidase K Proteins 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 102000016943 Muramidase Human genes 0.000 claims description 3
- 108010014251 Muramidase Proteins 0.000 claims description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 3
- 102000006382 Ribonucleases Human genes 0.000 claims description 3
- 108010083644 Ribonucleases Proteins 0.000 claims description 3
- 239000007984 Tris EDTA buffer Substances 0.000 claims description 3
- 230000004913 activation Effects 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 230000029087 digestion Effects 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000010812 external standard method Methods 0.000 claims description 3
- 239000004325 lysozyme Substances 0.000 claims description 3
- 229960000274 lysozyme Drugs 0.000 claims description 3
- 235000010335 lysozyme Nutrition 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 230000010355 oscillation Effects 0.000 claims description 3
- 235000020185 raw untreated milk Nutrition 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 2
- 239000012498 ultrapure water Substances 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 239000003463 adsorbent Substances 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 239000002054 inoculum Substances 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 abstract description 21
- 235000013336 milk Nutrition 0.000 abstract description 7
- 210000004080 milk Anatomy 0.000 abstract description 7
- 239000008267 milk Substances 0.000 abstract description 6
- 239000002253 acid Substances 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 8
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000005303 weighing Methods 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000014048 cultured milk product Nutrition 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000010413 mother solution Substances 0.000 description 2
- 238000009928 pasteurization Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- PKAUICCNAWQPAU-UHFFFAOYSA-N 2-(4-chloro-2-methylphenoxy)acetic acid;n-methylmethanamine Chemical compound CNC.CC1=CC(Cl)=CC=C1OCC(O)=O PKAUICCNAWQPAU-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 101710173142 Beta-fructofuranosidase, cell wall isozyme Proteins 0.000 description 1
- 150000008159 D-fructofuranosides Chemical class 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940000425 combination drug Drugs 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- YXVFQADLFFNVDS-UHFFFAOYSA-N diammonium citrate Chemical compound [NH4+].[NH4+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O YXVFQADLFFNVDS-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000021001 fermented dairy product Nutrition 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 235000014705 isoleucine Nutrition 0.000 description 1
- 229960003390 magnesium sulfate Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- CDUFCUKTJFSWPL-UHFFFAOYSA-L manganese(II) sulfate tetrahydrate Chemical compound O.O.O.O.[Mn+2].[O-]S([O-])(=O)=O CDUFCUKTJFSWPL-UHFFFAOYSA-L 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- 108010093591 phosphoenolpyruvate-sucrose phosphotransferase Proteins 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 229940070376 protein Drugs 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- YZYKBQUWMPUVEN-UHFFFAOYSA-N zafuleptine Chemical compound OC(=O)CCCCCC(C(C)C)NCC1=CC=C(F)C=C1 YZYKBQUWMPUVEN-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6818—Sequencing of polypeptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/245—Lactobacillus casei
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present disclosure a method for screening lactobacillus casei fermentation agent metabolizing sucrose. The method directionally screens the lactobacillus casei metabolizing sucrose through an amino acid, sequence of sucrose—6—phosphohydrolase, so as to use 5 the lactobacillus casei obtained through screening as a fermentation agent to apply to fermentation of milk products. Therefore, acid production of the lactobacillus casei in the fermented milk is facilitated, a fermentation rate is accelerated, the quality of the fermented milk is improved, and the method has 10 important application significance in screening of new fermentation agents. (+ Fig. l)
Description
METHOD FOR SCREENING LACTOBACILLUS CASEI FERMENTATION AGENT
METABOLIZING SUCROSE
The present disclosure belongs to the technical field of mi- crobiology and genetic engineering, and specifically to a method for screening lactobacillus casei fermentation agent metabolizing sucrose.
As a kind of typical fermented food, fermented milk has been consumed for thousands of years. The concept of "fermented milk" was first introduced by the Greeks in 100 B.C., and today it is consumed all over the world. A number of studies have shown that the fermented milk is high in vitamin and protein content and easy to absorb by intestinal tracts, and also has important physiologi- cal functions of reducing cholesterol and resisting tumor in addi- tion to having a function of regulating intestinal flora, such that fermented dairy products are highly favored by customers. The fermented milk products use cow milk as a main raw material, and are acidic dairy products prepared through lactic acid bacteria fermentation or common fermentation of lactic acid bacteria and yeast. As a milk product, the fermented milk products have been popular in the market for many years due to their unique taste and flavor. Studies have shown that main factors affecting the consum- ers to buy the fermented milk products are quality, price, availa- bility, and brand, of which quality is the most important, such that improving the quality of the fermented milk products is un- doubtedly the most important means for companies to cater to the market.
During preparation of the fermented milk, a base material is prepared by using pure milk or reconstituted whole milk, or su- crose; and fermentation is performed by adding a fermentation agent, and detection of total acid production, viscosity, microbi- al count, and volatile aroma components is performed after certain acidity or pH is reached, so as to finally evaluate the quality of the fermented milk. Lactose and sucrose metabolism is the main sugar source used by fermentation agent strains. The sucrose me- tabolism has four metabolic pathways. A phosphoenolpyruvate- sucrose phosphotransferase system is the predominant sucrose me- tabolism pathway in lactobacillus, and sucrose-6-phosphohydrolase is the most important rate-limiting enzyme, which is mainly used to hydrolyze end non-reducing B-D-fructofuranoside residues in p-
D-fructofuranoside. However, structural characterization of the sucrose-6-phosphohydrolase has been accomplished only in a few species of lactic acid bacteria (mainly including streptococcus mutans, escherichia coli, etc.), tiny changes in an amino acid se- quence of the sucrose-6-phosphohydrolase currently found can change the substrate specificity of the sucrose-6- phosphohydrolase, directly affecting a folding structure of the sucrose-6-phosphohydrolase, and thus causing differences in the metabolism of sucrose by the strains. Meanwhile, the substrate specificity of the sucrose-6-phosphohydrolase evolves with the strains, and significant differences in enzyme activity and pro- teins without enzyme activity are also found in homologs of other sucrose hydrolase.
Therefore, an urgent problem to be solved in the art is to accurately, rapidly and directionally screen a lactobacillus casei metabolizing sucrose to improve a fermentation acid production rate.
In order to overcome the problems in the related art, the present disclosure provides a method for screening a lactobacillus casei fermentation agent metabolizing sucrose. The method direc- tionally screens the lactobacillus casei metabolizing sucrose through an amino acid sequence of sucrose-6-phosphohydrolase, so as to use the lactobacillus casei obtained through screening as a fermentation agent to apply to fermentation of milk products.
Therefore, acid production of the lactobacillus casei in the fer- mented milk is facilitated, a fermentation rate is accelerated, the quality of the fermented milk is improved, and the method has important application significance in screening of new fermenta- tion agents.
In order to achieve the above purpose, the present invention may adopt the following technical scheme:
The present invention provides a method for screening a lac- tobacillus casei fermentation agent metabolizing sucrose, compris- ing the following steps:
S1, amplification of a sacA gene: extracting genomic DNA of the lactobacillus casei to be test- ed, and obtaining a full-length sequence of the sacA gene of the lactobacillus casei to be tested through amplification;
PCR primers amplifying the sacA gene comprise nucleotide se- quences shown as SEQ ID NO.1l and SEQ ID NO.2; 52, determination of an amino acid sequence of sucrose-6- phosphohydrolase of the lactobacillus casei to be tested: based on the full-length sequence of the sacA gene acquired in 81, determining the amino acid sequence of the sucrose-6- phosphohydrolase of the lactobacillus casei to be tested through software; and 83, comparison of the amino acid sequence of the sucrose-6- phosphohydrolase comparing the amino acid sequence, which is shown as SEQ ID
NO.3, of the sucrose-6-phosphohydrolase of the lactobacillus casei to be tested obtained in S2, and determining that the lactobacil- lus casei to be tested is able to metabolize sucrose.
Further, the method further comprising the following steps:
S4, verification of utilization of the lactobacillus casei to be tested on sucrose:
S41, activating the lactobacillus casei to be tested; and
S42, determining the utilization of the lactobacillus casei to be tested on the sucrose.
Further, extracting the genomic DNA of the lactobacillus ca- sel to be tested in S1 specifically comprises the following steps: inoculating the lactobacillus casei to be tested in a culture medium, culturing same in a stationary manner, when OD600 = 0.8- 1.0, taking bacterial liquid for centrifugation, removing superna- tant, adding a TES solution to the precipitate, so as to resuspend the bacteria, performing centrifugation, removing supernatant, then adding lysozyme to the bacteria to resuspend the bacteria,
performing digestion, then adding RNase to well mix, then adding a protease K solution to well mix, adding a buffer solution GB for oscillation, performing treatment in a water bath, adding anhy- drous ethanol to well mix, performing centrifugation, and pouring waste liquid; adding a buffer solution GD, performing centrifuga- tion, and pouring waste liquid; adding a washing solution PW for washing, performing centrifugation, and drying the residual wash- ing solution in an adsorbing material; and adding a preheated TE buffer solution dropwise, performing centrifugation, collecting samples, and preserving the samples at a low temperature for later use.
Further, in Sl, the sacA gene is amplified by using a PCR technology; an Ex Tag HS enzyme is selected to establish a 25 pL system; and PCR reaction conditions comprise: 95°C, 33min; [95°C, 30 s; 60°C, 30s; and 72°C, 2 min] x 30 cycles; 72°C, 5 min; and 4°C.
Further, in S4, S41 of activating the lactobacillus casei to be tested comprises the following specific steps: inoculating the lactobacillus casei to be tested in an MRS liquid culture medium, and culturing the lactobacillus casei to be tested at 37+1°C for 12h, and performing strain activation.
Further, in $4, S42 of determining the utilization of the lactobacillus casei to be tested on the sucrose comprises the fol- lowing specific steps: first, determining whether the lactobacillus casei to be tested is able to utilize the sucrose; inoculating the lactobacil- lus casei to be tested in an MRS liquid culture medium, and cul- turing the lactobacillus casei to be tested at 37+1°C for 12h, and detecting sucrose metabolism by the strain; then using the strain that is determined to be able to uti- lize the sucrose as a fermented milk base of a fermentation agent, and calculating a sucrose utilization rate; preparation of a fermented milk: mixing raw milk and the su- crose, performing homogenization and pasteurization, and preparing a fermentation base material after cooling; and inoculating the lactobacillus casei to be tested activated in the fermentation base material according to an addition of 5x10° CFU/g, and perform-
ing culture at 37 °C to obtain the fermented milk; and detection of sucrose content: accurately weighing a sucrose standard to a 100mL volumetric flask, making up to 100 mL with ul- trapure water, wherein mass concentrations of the sucrose respec- 5 tively are 3, 2.5, 2, 1.75, 1.50, 1.25, 1.0, 0.75, 0.50 and 0.25 mg/mL; plotting a standard curve by using the concentration of the standard as a horizontal coordinate and using a peak area as a longitudinal coordinate; weighing the fermented milk to a beaker, and adding deionized water for full dissolving with a magnetic stirrer; adding a Carrez reagent A and a Carrez reagent B in se- quence, and obtaining a mixture after full dissolving; centrifug- ing the mixture, and taking supernatant; diluting the supernatant with distilled water, and performing filtration by using a filter membrane; in combination with a chromatographic column and a dif- ferential Refractive Index Detector (RID), using a sulfuric acid aqueous solution as a mobile phase, and detecting the sucrose con- tent in a fermented milk sample by using an external standard method, so as to calculate the sucrose utilization rate.
The present disclosure has the following beneficial effects:
Existing technologies are short of methods for directionally screening the lactobacillus casei metabolizing sucrose by using amino acid sequencing means. Activated strains are still used and inoculated in a fermentation base material containing sucrose; and after a certain period of incubation, the utilization of the lac- tobacillus casei on the sucrose is determined by determining su- crose content in the base material and calculating a utilization rate of the sucrose, such that the methods are tedious in opera- tion and low in time consumption, and are limited and affected by a detection limit of an experimental equipment, operation tech- niques of testing personnel, making it difficult to guarantee the accuracy of the test. In the method of the present disclosure, the lactobacillus casei metabolizing sucrose is directionally screened through an amino acid sequence of sucrose-é-phosphohydrolase, such that the screening efficiency and accuracy of the lactobacillus casei fermentation agent are greatly improved, and the method has important application significance in screening of new fermenta- tion agents.
The present invention is further explained below in combina- tion with the accompanying drawings and the embodiments.
Fig. 1 is a comparison diagram of utilization of lactobacil- lus casei on sucrose in different groups.
Fig. 2 a comparison diagram of amino acid sequences of su- crose-6-phosphohydrolase SacA of lactobacillus casei strains in different groups.
Fig. 3 is a comparison diagram of sucrose content in ferment- ed milks in different groups.
The implementation of the invention is not limited to the following embodiments, and any form of adaptations and / or chang- es made to the invention will fall into the scope of protection of the invention. In the present invention, all the equipment and raw materials can be purchased from the market or commonly used in the industry. Unless otherwise specified, the method used in the em- bodiment is a general technique in the field.
The endpoints and any values of the range disclosed herein are not limited to that exact range or value and shall be under- stood to contain values close to these ranges or values. For nu- merical ranges, between endpoint values of each range, between endpoint values and individual point values, and individual point values may be combined to obtain one or more new numerical ranges, which shall be regarded as specifically disclosed herein.
Raw materials are shown in Table 1.
Table 1 ee lactobacillus casei N16, N17, N40, build the key laboratory of functional dairy prod-
N31, N80, N88 ucts sacA-F/R Sangon Biotech {Shanghai) Co., Ltd.
ExTaqHSenzyme | Takara Biomedical Technology (Beijing) Co., Ltd.
Lactose and sucrose standards | Sigma Aldrich (USA)
Experimental instruments are shown in Table 2.
Table 2 ==
HPX-87P (300 mmx7.8 mmx9 ym)
Bio Rad (USA) chromatographic column
Waters (USA)
Index Detector (RID)
This embodiment provided a method for screening a lactobacil- lus casei fermentation agent metabolizing sucrose, comprising the following steps:
Sl, amplification of a sacA gene: extracting genomic DNA of the lactobacillus casei to be test- ed, and obtaining a full-length sequence of the sacA gene of the lactobacillus casei to be tested through amplification.
Specific operation steps of genomic DNA included: inoculating the lactobacillus casei in an MRS liquid culture medium according to 1% (v/v) inoculation, and allowing same to stand at 37+1°C for culture; when OD600 = 0.8-1.0, taking 2.5 mL of bacterial liquid, performing centrifugation for 5 min at 4°C and 12000xg, and remov- ing supernatant; adding 2 mL of a TES solution to resuspend the bacteria, performing centrifugation for 5 min at 4°C and 12000xg; adding 200 pL of 50mg/mL lysozyme to resuspend the bacteria, and taking 200 g of the mixture, and performing digestion for 1.5h at 37°C; adding 20 pL of RNase (10 mg/mL), gently performing well mix- ing, and placing the mixture for 5 min at room temperature; adding 20 pL of a protease K solution, and gently performing well mixing; adding 220 pL of a buffer solution GB, performing oscillation for 15s, performing treatment for 10 min in a 70°C water bath, and per- forming short centrifugation; adding 220 uL of anhydrous ethanol, and performing well mixing for 15s; performing centrifugation for 30s at 12000xg, and pouring waste liquid; adding 500 pL of a buff- er solution GD, performing centrifugation for 30s at 12000xg, and pouring waste liquid; adding 700 pL of a washing solution PW, performing centrifugation for 30s at 12000xg, and then adding 500 nL of the washing solution PW for washing; performing centrifuga- tion for 2 min at 12000xg, placing the mixture for 7 min at room temperature, and drying the residual washing solution in an ad- sorbing material; and dropwise adding 50 uL of a TE buffer solu- tion preheated at 65°C-70°C, performing centrifugation for 2 min at 12000xg, then collecting samples, and preserving the samples at - 20°C for later use.
A formula of the MRS liquid culture medium included: dissolv- ing 5 g of anhydrous sodium acetate, 2 g of ammonium citrate diba- sic, 2 g of potassium phosphate dibasic, 0.58 g of magnesium sul- fate, 0.19 g of manganese sulfate tetrahydrate, 1mL of tween-80, 20 g of glucose, 10 g of peptone, 5 g of yeast extract powder, and 5 g of beef extract powder in 900 mL of deionized water, regulat- ing a pH value to 6.5 with 1 mol/L of sodium hydroxide, and making up to 1 L; and performing autoclaved sterilization for 15 min at 121°C.
The TES solution was prepared by adding 25 g of sucrose, 5 mL of a Tris-Cl mother solution (1 M, pH=8.0), and 6 mL of an EDTA mother solution (0.5 M, pH=8.0), regulating pH to 8.0, making up to 100 mL with deionized water, performing autoclaved steriliza- tion for 15 min at 121°C, and performing preservation at room tem- perature.
A sacA gene was amplified, sacA-F/R was used as a PCR primer, and nucleotide sequences of sacA-F and sacA-R were shown as SEQ ID
NO.1 and SEQ ID NO.2. sacA-F!:5'- CAAGGTGGTAAGTTCTGGGGGTAACATTTCAAACAAGST -3'; sacA-R:5!- GCTTGCGACAAGCCTTACGTTGTGGCGACA -3!.
The sacA gene is amplified by using a PCR technology; an Ex
Tag HS enzyme is selected to establish a 25 pL system; and PCR re- action conditions comprise: 95°C, 3min; [95°C, 30 s; 60°C, 30s; and 72°C, 2 min] x 30 cycles; 72°C, 5 min; and 4°C. 82, determination of an amino acid sequence of sucrose-&6- phosphohydrolase of the lactobacillus casei to be tested: based on the full-length sequence of the sacA gene acquired in 31, determining the amino acid sequence of the sucrose-6- phosphohydrolase of the lactobacillus casei to be tested through software; and 33, comparison of the amino acid sequence of the sucrose-6- phosphohydrolase comparing the amino acid sequence, which is shown as SEQ ID
NO.3, of the sucrose-6-phosphohydrolase of the lactobacillus casei to be tested obtained in S2, and determining that the lactobacil- lus casei to be tested is able to metabolize sucrose. 54, verification of utilization of the lactobacillus casei to be tested on sucrose:
S41, activating the lactobacillus casei to be tested:
The lactobacillus casei to be tested was inoculated in the
MRS according to a 1% (v/v) addition amount, and cultured at 37+1°C for 12h for strain activation.
S42, determining the utilization of the lactobacillus casei to be tested on the sucrose:
D Detection of growth of strains
Strains were inoculated in an S-MRS culture medium according to a final concentration of 1x10’ CFU/mL, ODss and pH values were measured every 2h, the growth of the strains was determined, and this experiment was performed for three biological replicates. 2) Determination of sucrose content in fermented milk 93% (w/w) raw milk and 5% (w/w) sucrose were mixed and homog- enized through 20MPa, pasteurization was performed for 5 min at 95°C, the milk was cooled to 37 °C, and a fermentation base materi- al was obtained through preparation. The lactobacillus casei to be tested was inoculated in the fermentation base material according to an addition of 5x10° CFU/g, and was cultured for 24h at 37°C, and 3 biological replicates were performed.
Accurately weighing a sucrose standard to a 100mL volumetric flask, making up to 100 mL with ultrapure water, wherein mass con- centrations of the sucrose respectively are 3, 2.5, 2, 1.75, 1.50, 1.25, 1.0, 0.75, 0.50 and 0.25 mg/mL; plotting a standard curve by using the concentration of the standard as a horizontal coordinate and using a peak area as a longitudinal coordinate. 5.0 g of the fermented milk was weighed and placed to a 100mL beaker, and 25.0 g of deionized water was added and fully dissolved by using a mag-
netic stirrer; 2.5 mL of a Carrez reagent A and 2.5mL of a Carrez reagent B were added in sequence and were fully dissolved for 30 min, so as to obtain a mixture; centrifugation was performed on the mixture for 15 min at 5000xg; supernatant was diluted to 100 mL with distilled water, and was filtered through a 0.22 um filter membrane; and in combination with a Bio-Rad Aminex® HPX-87P (300 mmx7.8 mmx9 um) chromatographic column and a 2414-type differen- tial Refractive Index Detector (RID), a 5mM sulfuric acid aqueous solution was used as a mobile phase, with a flow rate being 550 pL/min, a column temperature was set to 60 °C, a sample size was 2
HL, and lactose and sucrose content in samples was detected by us- ing an external standard method, so as to calculate a utilization rate of sucrose.
The Carrez reagent A was prepared by weighing 10.60 g of po- tassium ferrocyanide, and dissolving same to 100 mL with deionized water. The Carrez reagent B was prepared by weighing 21.90 g of zinc acetate dihydrate, dissolving same with the deionized water, adding 3 mL of acetic acid for dissolving, and making the mixture up to 100 mL.
In this embodiment, six lactobacillus casei strains were se- lected, respectively being LC N16, N17, N31, N40, N80, and N88.
Metabolic effects of the six strains on the sucrose were respec- tively determined according to the above method.
Result analysis:
The growth of each lactobacillus casei strain was shown in
Fig. 1. When the sucrose was a single sugar source, the growth of the LC N16, the N17, and the N40 entered a logarithmic phase at 4 hours, and entered a stable phase at 12 hours; and when the su- crose was the single sugar source, OD600 values of the LC N31, the
N80, and the N88 were all less than 0.250 within 16 hours, indi- cating that these three strains did not utilize the sucrose.
Amino acid sequences of the sucrose-6-phosphohydrolase SacA of the LC N16, N17, and N40 strains were compared with amino acid sequences of the sucrose-€-phosphohydrolase SacA of the LC N31,
N80, and N88 strains. Results were shown in Fig. 2. 5 amino acids (Valine, threonine, asparagine, leucine, and valine) of p- fructosidase SacA in the LC N16, the N17, and the N40 were differ-
ent from that in an LC group (Isceucine, alanine, serine, phenyl- alanine, isoleucine). When mutating from threonine to alanine, the polarity and charge of the amino acid was changed.
The amino acid sequence of the sucrose-6-phosphchydrolase
SacA of the lactobacillus casei utilizing the sucrose was shown as
SEQ ID NO.3. Specifically:
HFKOGGKFMKEATWSTAARYQPYSSWAPDY IMKLKAQVAAS—
KWRTKTHVQPDTGLINDPCSLNEEFNNKWHLYYQQFPEFGPVHGLKSWA—
HAVSKDLENWRRVPGDLLPDNEYDSHGAYTGSALVTHGTLRLMYTGNARDDOWHRHSTQL-
GAVLGADGRLFKDPKPLVLTPPTGYTQEFRDPFLENYEGQTYVLIGGQRPDHTGAIL-
LYAKQTDKSWREVAPLSIPDEFCGYMVECPNITFINGKVVLVYCPQGLDODEFPEYENVYP-
NIALVADSFDPTTGNLTHORLONIDKGEDEYATRLANTDDDGTLAISWLGLPDTTYPTDDDG-
WAGVLSYVROLTLRDDHVCLYPHPAIKNLRETAVEDLPVIQQHDDEWTVTNLEGAFELALT-
LAAGOKTTIHLPDGDHDOLLIHLDSDSGQGMIQRENRN-
NGGSLRQFGFPAGKTVEIRLEIDVSVFELFIDOGYRVVSGRFFGNEAPTAA-
RVTPPSAASDVVSWNLKKDNGGL.
Determination results of the sucrose content in the fermented milk were shown in Fig. 3. Sucrose consumed by the LC N16, N17, and N40 strains respectively was 1.2 g, 1.43 g, and 1.35 g, and sucrose utilization rates respectively were 24%, 28.6%, and 27%; and sucrose consumed by the LC N31, N80, and N88 strains respec- tively was 0.028 g, 0.027 g, and 0.029 g, and sucrose utilization rates respectively were 0.56%, 0.54%, and 0.58%. It was verified that the lactobacillus casei metabolizing sucrose was directional- ly screened by using the amino acid sequence of the sucrose-6- phosphohydrolase.
In summary the technical problem to be urgently solved ex- pected to use the lactobacillus casei metabolizing sucrose direc- tionally screened based on the amino acid sequence of the sucrose- 6-phosphohydrolase as a fermentation agent to apply to fermenta- tion of milk products, so as to accelerate a fermentation rate, thereby improving the quality of the fermented milk.
Finally, it should be noted that the above is only used to explain the technical scheme of the invention rather than the lim- itation, although the invention is explained in detail according to the better arrangement scheme, the ordinary technicians in the field should understand that the technical scheme of the invention can be modified or replaced, without breaking away from the spirit and scope of the technical scheme of the invention.
1 Sm overs lon=TL00 eooonling=TUTE-gn vn 7 <!DOCTYPE ST26SequenceListing PUBLIC "-//WIPO//DTD Sequence Listing 1.3//EN" "3T26Sequencelisting V1 3.dtd"> 3 <STZéSequenceldiastling originaiFrasTervlanguageloede=an" noniinglishPreeTaxtLanguagyeloda=s
Taht diaVersion=tVl 3% fileNems="ROENSRALSÍNIDJ xml" soflwareNem="WIPO Seguanaa® suftwaraVersion="2, 3,0 predaationis a=" 2034-04-18 4 <Applicationidenitification> <IPOGfficeCtode>NL/IPOfficetode»> © <ApplicationNumberTexts></ApplicaticoNunberText> 3 <FilingBater</Filingdate> 2 </Applicationidentification> 3 <ApplicentFileReference>CAU/AppiicantFileReference» if <HarliestPrioritvyApplicationldentification>
Ll <IPOEficeCode>CN“/IPOfficelodes> 12 <ApplicationNumberText>2023113387280</ApplicationNvmberText> ij <Filinglater»2023-10-17</Filinglate> ië </EarliestPriorityApplicationldentificaticon»>
Lj <ApplicantName langvacenvie="enV>Hunan Agricultural University</ApplicantName iE <ApplicantNamelLatin»Hunan Agricultural University</ApplicantMamaLatio>
Lj <InvenlorName langvagecode="en'>Luo Jied/InvenlorName>
LS <InventorNamelatin>Luo Jie</InventorNameLatin>
Le <inventionTictie languaysticde="an">Method for Screening Lactobacillus Casei
Fermentation Agent Metabolizing Sucrose /InventionTiile> 240 <{SequenceTotalDuantiity>3</JeguenceTotalQuantity> 2 <Sedquencslbata seguencslóNumboer="iN» de <INSDseq> 23 <INSDSeq length>39</INSDSeqg length gd <INSDSeq moltype>DNA“/INSDSeg moltype> <INSDSeq division>PAT</INSDSeq division» “8 <“INSDSeq feature-tabled> 27 <INSDFeature> as “INSDFearure Keyrsource</INSDFesture key> as “INSDFearvure location>l..39</INSDFesture location» <INSDFeatura gquals>
SL <INSDQualifler>
SE <INSDQualifier name>mol type“ /INSDQualijier named 33 <INSDQualiflsr valus>unassigned DNA</IN3DQualifier value sd </INSDOualiiier»>
Si CINSDQualifler id=Ng3\> is <INSDgualifier nams>organism</INEDQualifier name> 37 <INSDgualifiesr valussArtificial Sequence <fINSDQualifier value» 2e </INSDDualifier> 28 </INSDFeature guals> 44 </INSDFeature»> u
Zl </INSDSeg feature-table> 42 <INSDSeq sequence>caaggtggtaagttctgggggtaacatttcaaacaaggt </INSDEeg sequence an </INSDSeas 44 </Beguancelata> 4% <SequenceData sspuencelDlumber="3%> 48 <INSDSeq> a <INSDEeq length>30</INSDSeq length» 48 <INSDSeq moltype>DNA</INSDSeg moltvper <INSDSeq division>PAT</INSDIeq division> 5G <INSDSeq featbure-table>
Si <INSDFeaturse>
SE <INSDFeature key>source</INIDFeature key> 53 <INSDFeature location>l..30</INSDFeature location»
D4 <INSDFeature qualss u <<INSDQualiifier>
SE <“INSDQualifier nawmermol type</INSDQualifier name> 57 <INSDQualifier value>unassigned DNA</IN3UQualifier value
NS] </INSDOualifiers» u - is <INSDQvelijier ic="gd"x>
Si <INSDQualifier naemsrorganism“/INSDQualijier named
Gl <INSDQualifiasr valus>Artificial Sequence </INSDQualifier value» 62 </INSDOualifiers 83 </INShFeaiturs guals> 54 </INSDFeature>
Sn <“/INSDBeg featurertablex
Le <INSDSeq sequencergettgegacaagecttacgttgtggegaca“/INSDSeqg saquences 7 </INSDSaea>
Ga </SanguenceData>
SE <HegquenceData seguantalhMunhag="3T>
Fi LINSDSeg>
JL <INSDSeq length>500</INSDSeq lengith>
Es <INSDSeq moltype>AA</INSDSeq moliype> 73 <INSDSeq division>PAT</INSDSeq division»
Ta <INSDSeq feature-tablex 35 <INSDFearure:
Ta <INSDFesture keyrsource</INSDFesture key» 77 <INSDFeature location»l1..500</INSDFeature location» js <INSDFeature guals>
TG CINSDQualifier> 80 <INSDQualifier name> mol type“/INSDQualifier name>
Si <INSDQualifier value>protein</INSDQualifier value» 22 </INSDOQualifiern> 23 CINSDQualifiler L4=9gin> 24 <INSDgualifier namevorganism“/INSDQualifier nams> 2 <INSDQualiiler value» Lacticaseibacillus casei <SINSDRualifier values dE </INSDQualifien u
SY “/INSDFeature quals:» </INSDFeatura> -
Gu </INSDSeg feature-table> où <INSDSeq sequence»
HFKQGGKFMKEATWSTAARYQPYSSWAPDY IMKLKAQVAASKWRTKTHVQPDTGLINDPCSLNFFNNKWHLYYQ
QFPFGPVHGLKSWAHAVSKDLFNWRRVPGDLLPDNEYDSHGAY TGSALVTHGTLRLMY TGNARDDQWHRHSTQL
GAVLGADGRLFKDPKPLVLTPPTGY TQEFRDPFLFNYEGQTYVLIGGQRPDHTGAILLYAKQTDKSWREFVAPLS
IPDEFCGYMVECPNITFINGKVVLVYCPQGLDOQDFFEYENVYPNIALVADSFDPTTGNLTHQRLONIDKGFDFY
ATRLANTDDDGTLAI SWLGLPDTTYPTDDDGWAGVLSYVRQLTLRDDHVCLYPHPATKNLRETAVEDLPVIQQH
DDEWTVTNLEGAFELALTLAAGQKTTIHLPDGDHDQLLIHLDSDSGQGMIQRENRNNGGSLRQFGFPAGKTVEI
RLFIDVSVFELFIDQGYRVVSGRFFGNEAPTAARVTPPSAASDVVSWNLKKDNGGL
<{/INSDSeg sequencer
Si </INSDSeg> zl </SequencebData>
EN </ST26Segqvencelisting»>
Claims (6)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311338728.0A CN117074699B (en) | 2023-10-17 | 2023-10-17 | Method for screening lactobacillus casei starter for metabolizing sucrose |
Publications (1)
Publication Number | Publication Date |
---|---|
NL2037597A true NL2037597A (en) | 2024-06-03 |
Family
ID=88704721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL2037597A NL2037597A (en) | 2023-10-17 | 2024-05-02 | Method for screening lactobacillus casei fermentation agent metabolizing sucrose |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN117074699B (en) |
NL (1) | NL2037597A (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100277348B1 (en) * | 1998-12-03 | 2001-01-15 | 이은선 | Lactobacillus Kasei Kay Y, a new lactic acid bacterium that ferments mistletoe 22713 |
US20060143729A1 (en) * | 2004-06-30 | 2006-06-29 | Ceres, Inc. | Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
US7459289B2 (en) * | 2004-03-08 | 2008-12-02 | North Carolina State University | Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
JP2011505869A (en) * | 2007-12-18 | 2011-03-03 | コリア アドバンスド インスティチュート オブ サイエンス アンド テクノロジィ | Genetically modified microorganisms with sucrose metabolism |
US8673602B2 (en) * | 2011-08-16 | 2014-03-18 | E I Du Pont De Nemours And Company | Recombinant bacteria having improved sucrose utilization |
CN103555690B (en) * | 2013-10-28 | 2016-05-25 | 光明乳业股份有限公司 | A kind of Novel fruit glycosidase and encoding gene and application |
EP4341276A1 (en) * | 2021-05-17 | 2024-03-27 | DSM IP Assets B.V. | Novel technology to enable sucrose utilization in strains for biosyntetic production |
-
2023
- 2023-10-17 CN CN202311338728.0A patent/CN117074699B/en active Active
-
2024
- 2024-05-02 NL NL2037597A patent/NL2037597A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN117074699A (en) | 2023-11-17 |
CN117074699B (en) | 2024-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Qian et al. | Cooperation within the microbial consortia of fermented grains and pit mud drives organic acid synthesis in strong-flavor Baijiu production | |
Jensen et al. | Metabolic behavior of Lactococcus lactis MG1363 in microaerobic continuous cultivation at a low dilution rate | |
Tejedor-Sanz et al. | Extracellular electron transfer increases fermentation in lactic acid bacteria via a hybrid metabolism | |
CN109913523B (en) | Culture medium for screening nitrogen source suitable for proliferation of bifidobacteria | |
CN113832083B (en) | Bacillus beleisi and application thereof in vinegar brewing | |
Jansen et al. | Prolonged maltose-limited cultivation of Saccharomyces cerevisiae selects for cells with improved maltose affinity and hypersensitivity | |
CN110093285B (en) | Acid-resistant lactobacillus fermentum and application thereof | |
CN114196566B (en) | Streptococcus thermophilus JMCC0033 and application thereof | |
CN111500554A (en) | Preparation and application of high-activity β -xylosidase | |
Nishita et al. | Development of media to accelerate the isolation of indigo-reducing bacteria, which are difficult to isolate using conventional media | |
CN108410918B (en) | Tryptophan fermentation medium and tryptophan fermentation method | |
CN102382790A (en) | Recombinant bacillus subtilis for high yield of catalase (CAT), and construction method and application thereof | |
NL2037597A (en) | Method for screening lactobacillus casei fermentation agent metabolizing sucrose | |
CN101939422B (en) | Spray dried microbes and methods of preparation and use | |
CN102286614A (en) | Gene capable of regulating and controlling inhibition of vitamin C fermented strain acid production during acid stress | |
Mao et al. | Succession of microbial community of the pit mud under the impact of Daqu of Nongxiang Baijiu | |
CN110396489A (en) | A kind of artificial yeast for brewing rice wine leavening of yellow rice wine and its application method | |
CN116179376A (en) | Preparation process for producing single-cell protein based on acetic acid as raw material | |
CN101177686B (en) | Acetonic acid oxidase gene, recombinant expression plasmid and transformation strains thereof | |
CN109593701B (en) | Acid-resistant recombinant lactic acid bacteria and construction method thereof | |
Márquez-López et al. | Comparative analysis of enzymatic activity of tannase in non-conventional yeasts to produce ellagic acid | |
CN109852571B (en) | Acid-resistant lactobacillus engineering bacterium and construction method and application thereof | |
CN104278086A (en) | Method for detecting lactic acid bacteria in fermented dairy product | |
Ramon-Portugal et al. | Kinetic study and mathematical modelling of killer and sensitive S. cerevisiae strains growing in mixed culture | |
CN114958630B (en) | Pichia pastoris strain capable of producing glucuronic acid and application thereof |